Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Wolf, Maija ^a,b   Korja, Miikka ^c,d   Karhu, Ritva ^e   Edgren, Henrik ^a,b   Kilpinen, Sami ^a   Ojala, Kalle ^a   Mousses, Spyro ^f   Kallioniemi, Anne ^e   Haapasalo, Hannu ^g  

^a UNIVERSITY OF HELSINKI   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF TAMPERE   (Finland)

^f TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^g TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE SERINE RICH COILED COIL 2 PROTEIN; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE 4; KINETOCHORE ASSOCIATED 1 PROTEIN; M PHASE PHOSPHOPROTEIN 9; MYCN PROTEIN; MYELOID ECOTROPIC VIRAL INTEGRATION SITE 1 HOMOLOG PROTEIN; ONCOPROTEIN; PARAFFIN; PROTEIN MDM2; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; DNA; RNA; TUMOR MARKER;

AMPLICON; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CHROMOSOME 12Q; CHROMOSOME 2P; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER MODEL; CONTROLLED STUDY; COPY NUMBER VARIATION; DATA MINING; EMBEDDING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PROGNOSIS; CHROMOSOME 12; CHROMOSOME ABERRATION; DNA MICROARRAY; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 12; COMPARATIVE GENOMIC HYBRIDIZATION; DATA MINING; DNA, NEOPLASM; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEUROBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RNA, NEOPLASM; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 77951872238     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-181     Document Type: Article

References (51)

1. Schwab M, Alitalo K, Klempnauer K-H, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and neuroblastoma tumour. Nature 1983, 305:245-248. 10.1038/305245a0, 6888561.
2. Schwab M, Westermann F, Hero B, Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol 2003, 4:472-480. 10.1016/S1470-2045(03)01166-5, 12901961.
3. Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK. The International Neuroblastoma Risk Group (INRG) classification system: an INRG task force report. J Clin Oncol 2009, 27:289-297. 10.1200/JCO.2008.16.6785, 2650388, 19047291.
4. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993, 11:1466-1477.
5. Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J, Van Roy N. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 1999, 340:1954-1961. 10.1056/NEJM199906243402504, 10379019.
6. Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Boecker W, Lampert F, Stoerkel S. Comparative genomic hybridization (CGH) analysis of neuroblastomas - an important methodological approach on paediatric tumour pathology. J Pathol 1997, 181:394-400. 10.1002/(SICI)1096-9896(199704)181:4<394::AID-PATH800>3.0.CO;2-1, 9196436.
7. Caron H, van Sluis P, de Kraker J, Bokkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voute PA, Versteeg R. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 1996, 334:225-230. 10.1056/NEJM199601253340404, 8531999.
8. Chen Q-R, Bilke S, Wei JS, Whiteford CC, Cenacchi N, Krasnoselsky AL, Greer BT, Son C-G, Westermann F, Berthold F, Schwab M, Catchpoole D, Khan J. cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma. BMC Genomics 2004, 5:70. 10.1186/1471-2164-5-70, 520814, 15380028.
9. Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, Cole K, Mossé YP, Wood A, Lynch JE, Pecor K, Diamond M, Winter C, Wang K, Kim C, Geiger EA, McGrady PW, Blakemore AI, London WB, Shaikh TH, Bradfield J, Grant SF, Li H, Devoto M, Rappaport ER, Hakonarson H, Maris JM. Copy number variation at 1q21.1 associated with neuroblastoma. Nature 2009, 459:987-991. 10.1038/nature08035, 2755253, 19536264.
10. Mora J, Cheung N-K V, Oplanich S, Chen L, Gerald WL. Novel regions of allelic imbalance identified by genome-wide analysis of neuroblastoma. Cancer Res 2002, 62:1761-1767.
11. Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol 1997, 150:81-89. 1858505, 9006325.
12. Rubie H, Hartmann O, Michon J, Frappaz D, Coze C, Chastagner P, Baranzelli MC, Plantaz D, Avet-Loiseau H, Benard J, Delattre O, Favrot M, Peyroulet MC, Thyss A, Perel Y, Bergeron C, Courbon-Collet B, Vannier JP, Lemerle J, Sommelet D. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 1997, 15:1171-1182.
13. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985, 313:1111-1116.
14. Su WT, Alaminos M, Mora J, Cheung N-K, La Quaglia MP, Gerald WL. Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas. Cancer Genet Cytogenet 2004, 154:131-137. 10.1016/j.cancergencyto.2004.02.009, 15474148.
15. Van Roy N, Van Limbergen H, Vandesompele J, Van Gele M, Poppe B, Salwen H, Laureys G, Manoel N, De Paepe A, Speleman F. Combined M-FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines. Genes Chromosom Cancer 2001, 32:126-135. 10.1002/gcc.1174, 11550280.
16. Mosse YP, Greshock J, Margolin A, Naylor T, Cole K, Khazi D, Hii G, Winter C, Shahzad S, Asziz MU, Biegel JA, Weber BL, Maris JM. High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosom Cancer 2005, 43:390-403. 10.1002/gcc.20198, 15892104.
17. Scaruffi P, Coco S, Cifuentes F, Albino D, Nair M, Defferrari R, Mazzocco K, Tonini GP. Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization. Cancer Genet Cytogenet 2007, 177:20-29. 10.1016/j.cancergencyto.2007.05.002, 17693187.
18. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
19. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 1999, 86:364-372. 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7, 10421273.
20. Korja M, Finne J, Salmi TT, Kalimo H, Karikoski R, Tanner M, Isola J, Haapasalo H. Chromogenic in situ hybridization -detected hotspot MYCNamplification associates with Ki-67 expression and inversely with nesting expression in neuroblastomas. Mod Pathol 2005, 18:1599-1605.
21. Andersen CL, Hostetter G, Grigoryan A, Sauter G, Kallioniemi A. Improved procedure for fluorescence in situ hybridization on tissue microarrays. Cytometry 2001, 45:83-86. 10.1002/1097-0320(20011001)45:2<83::AID-CYTO1149>3.0.CO;2-P, 11590619.
22. Kilpinen S, Autio R, Ojala K, Iljin K, Bucher E, Sara H, Pisto T, Saarela M, Skotheim RI, Björkman M, Mpindi J-P, Haapa-Paananen S, Vainio P, Edgren H, Wolf M, Astola J, Nees M, Hautaniemi S, Kallioniemi O. Systematic bioinformatic analysis of expression levels of 17330 human genes across 9783 samples from 175 types of healthy and pathological tissues. Genome Biol 2008, 9:R139. 10.1186/gb-2008-9-9-r139, 2592717, 18803840.
23. Autio R, Kilpinen S, Saarela M, Kallioniemi O, Hautaniemi S, Askola J. Comparison of Affymetrix data normalization methods using 6,926 experiments across five array generations. BMC Bioinformatics 2009, 30(10 Suppl 1):S24.
24. Ambros PF, Ambros IM, Kerbl R, Luegmayr A, Rumpler S, Ladenstein R, Amann G, Kovar H, Horcher E, De Bernardi B, Michon J, Gadner H. Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas. Med Pediatr Oncol 2001, 36:1-4. 10.1002/1096-911X(20010101)36:1<1::AID-MPO1002>3.0.CO;2-L, 11464855.
25. Mosse YP, Diskin SJ, Wasserman N, Rinaldi K, Attiyeh EF, Cole K, Jagannathan J, Bhambhani K, Winter C, Maris JM. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression. Genes Chromosom Cancer 2007, 46:936-949. 10.1002/gcc.20477, 17647283.
26. Kashkar H, Haefs C, Shin H, Hamilton-Dutoit SJ, Salvesen GS, Kronke M. XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells. J Exp Med 2003, 198:341-7. 10.1084/jem.20021279, 2194071, 12874265.
27. Kashkar H, Seeger JM, Hombach A, Deggerich A, Yazdanpanah B, Utermohlen O. XIAP targeting sensitizes Hodgkin lymphoma cells for cytolytic T-cell attack. Blood 2006, 108:3434-40. 10.1182/blood-2006-05-021675, 16868249.
28. Arellano-Llamas A, Garcia FJ, Perez D, Cantu D, Espinosa M, De la Garza JG, Maldonado V, Melendez-Zajgla J. High Smac/DIABLO expression is associated with early local recurrence of cervical cancer. BMC Cancer 2006, 6:256. 10.1186/1471-2407-6-256, 17067390.
29. Espinosa M, Cantu D, Lopez CM, De la Garza JG, Maldonado VA, Melendez-Zajgla J. SMAC is expressed de novo in a subset of cervical cancer tumours. BMC Cancer 2004, 4:84. 10.1186/1471-2407-4-84, 535940, 15560849.
30. Shibata T, Mahotka C, Wethkamp N, Heikaus S, Gabbert HE, Ramp U. Disturbed expression of the apoptosis regulators XIAP, XAF1, and Smac/DIABLO in gastric adenocarcinomas. Diagn Mol Pathol 2007, 16:1-8. 10.1097/01.pdm.0000213471.92925.51, 17471152.
31. Bao ST, Gui SQ, Lin MS. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2006, 5:580-583.
32. Mizutani Y, Nakanishi H, Yamamoto K, Li YN, Matsubara H, Mikami K. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance. J Clin Oncol 2005, 23:448-454. 10.1200/JCO.2005.02.191, 15572731.
33. Sekimura A, Konishi A, Mizuno K, Kobayashi Y, Sasaki H, Yano M. Expression of Smac/DIABLO is a novel prognostic marker in lung cancer. Oncol Rep 2004, 11:797-802.
34. Beheshti B, Braude I, Marrano P, Thorner P, Zielenska M, Squire JA. Chromosomal localization of DNA amplifications in neuroblastoma tumours using cDNA microarray comparative genomic hybridization. Neoplasia 2003, 5:53-62. 1502121, 12659670.
35. De Preter K, Pattyn F, Berx G, Strumane K, Menten B, Van Roy F, De Paepe A, Speleman F, Vandesompele J. Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons. BMC Genomics 2004, 5:11. 10.1186/1471-2164-5-11, 365025, 15018647.
36. Schwab M, Ellison J, Busch M, Rosenau W, Varmus HE, Bishop J. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci USA 1984, 81:4940-4944. 10.1073/pnas.81.15.4940, 391608, 6589638.
37. Spieker N, van Sluis P, Beitsma M, Boon K, van Schaik BDC, van Kampen AHC, Caron H, Versteeg R. The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32. Genomics 2001, 71:214-221. 10.1006/geno.2000.6408, 11161815.
38. Van Roy N, Forus A, Myklebost O, Cheng NC, Versteeg R, Speleman F. Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP. Cancer Genet Cytogenet 1995, 82:151-154. 10.1016/0165-4608(95)00034-M, 7664245.
39. Fix A, Lucchesi C, Ribeiro A, Lequin D, Pierron G, Schleiermacher G, Delattre O, Janoueix-Lerosey I. Characterization of amplicons in neuroblastoma: high-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes. Genes Chromosom Cancer 2008, 47:819-834. 10.1002/gcc.20583, 18553563.
40. Carén H, Erichsen J, Olsson L, Enerbäck C, Sjöberg RM, Abrahamsson J, Kogner P, Martinsson T. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene. BMC Genomics 2008, 9:353. 10.1186/1471-2164-9-353, 2527340, 18664255.
41. Kobayashi K, Era T, Takebe A, Jakt LM, Nishikawa S-I. ARID3B induces malignant transformation of mouse embryonic fibroblasts and is strongly associated with malignant neuroblastoma. Cancer Res 2006, 66:8331-8336. 10.1158/0008-5472.CAN-06-0756, 16951138.
42. Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D, Seiser E, Jagannathan J, Shusterman S, Bansal M, Khazi D, Winter C, Okawa E, Grant G, Cnaan A, Zhao H, Cheung NK, Gerald W, London W, Matthay KK, Brodeur GM, Maris JM. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res 2006, 66:6050-6062. 10.1158/0008-5472.CAN-05-4618, 16778177.
43. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 2004, 101:6062-6067. 10.1073/pnas.0400782101, 395923, 15075390.
44. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A, Patapoutian A, Hampton GM, Schultz PG, Hogenesch JB. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 2002, 99:4465-4470. 10.1073/pnas.012025199, 123671, 11904358.
45. Khaitovich P, Muetzel B, She X, Lachmann M, Hellmann I, Dietzsch J, Steigele S, Do HH, Weiss G, Enard W, Heissig F, Arendt T, Nieselt-Struwe K, Eichler EE, Pääbo S. Regional pattern of gene expression in human and chimpanzee brains. Genome Res 2004, 14:1462-1473. 10.1101/gr.2538704, 509255, 15289471.
46. Franz H, Ullmann C, Becker A, Ryan M, Bahn S, Arendt T, Simon M, Pääbo S, Khaitovich P. Systematic analysis of gene expression in human brains before and after death. Genome Biol 2005, 6:R112. 10.1186/gb-2005-6-13-r112, 1414111, 16420671.
47. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 2004, 101:2173-2178. 10.1073/pnas.0308512100, 357071, 14769913.
48. Vawter MP, Evans S, Choudary P, Tomita H, Meador-Woodruff J, Molnar M, Li J, Lopez JF, Myers R, Cox D, Watson SJ, Akil H, Jones EG, Bunney WE. Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology 2004, 29:373-384. 10.1038/sj.npp.1300337, 14583743.
49. Ge X, Yamamoto S, Tsutsumi S, Midorikawa Y, Ihara S, Wang SM, Aburatani H. Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005, 86:127-141. 10.1016/j.ygeno.2005.04.008, 15950434.
50. Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 2006, 11:965-978. 10.1038/sj.mp.4001875, 16894394.
51. Deng V, Matagne V, Banine F, Frerking M, Ohliger P, Budden S, Pevsner J, Dissen GA, Sherman LS, Ojeda SR. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum Mol Genet 2007, 16:640-650. 10.1093/hmg/ddm007, 17309881.